Loading...
Keywords
Last Name
Institution

Hugo Escobar

Concepts (126)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
4
2021
19
0.940
Why?
Lung Diseases
3
2017
26
0.700
Why?
Aminophenols
2
2018
2
0.490
Why?
Quinolones
2
2018
2
0.490
Why?
Benzodioxoles
2
2018
2
0.490
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
2
2018
3
0.490
Why?
Pseudomonas Infections
1
2021
7
0.430
Why?
Bronchopulmonary Dysplasia
3
2018
41
0.390
Why?
Pyrrolidines
1
2018
1
0.350
Why?
Chloride Channel Agonists
1
2018
1
0.350
Why?
Pyrazoles
1
2018
2
0.350
Why?
Indoles
1
2018
3
0.350
Why?
Respiratory Insufficiency
2
2018
10
0.330
Why?
Nitric Oxide
2
2018
6
0.330
Why?
Humans
12
2023
6129
0.270
Why?
Respiratory Function Tests
3
2018
13
0.240
Why?
Intensive Care Units, Pediatric
1
2023
10
0.240
Why?
Hospitalization
2
2023
183
0.240
Why?
Forced Expiratory Volume
3
2021
10
0.230
Why?
Lung
3
2018
74
0.210
Why?
Male
9
2018
3180
0.200
Why?
Infant, Premature, Diseases
2
2018
23
0.200
Why?
Infant, Newborn
6
2023
809
0.190
Why?
Administration, Inhalation
3
2021
18
0.180
Why?
Female
8
2018
3284
0.170
Why?
Exercise Tolerance
1
2018
3
0.170
Why?
Bronchodilator Agents
1
2018
11
0.170
Why?
Microsurgery
1
2018
1
0.170
Why?
Mycobacterium avium Complex
1
2018
1
0.170
Why?
Bronchitis
1
2018
2
0.170
Why?
Laser Therapy
1
2018
4
0.170
Why?
Mycobacterium avium-intracellulare Infection
1
2018
2
0.170
Why?
Bronchoalveolar Lavage Fluid
1
2018
12
0.170
Why?
Antitubercular Agents
1
2018
7
0.170
Why?
Intermittent Positive-Pressure Ventilation
1
2017
2
0.160
Why?
Interactive Ventilatory Support
1
2017
2
0.160
Why?
Prospective Studies
3
2021
489
0.160
Why?
Energy Metabolism
1
2017
25
0.160
Why?
Fluorescent Dyes
1
2017
5
0.160
Why?
Flow Cytometry
1
2017
26
0.160
Why?
Exhalation
1
2017
1
0.160
Why?
Tracheostomy
1
2017
11
0.160
Why?
Antibodies, Monoclonal
1
2017
23
0.160
Why?
Aminopyridines
1
2015
2
0.140
Why?
Steroids
1
2013
12
0.120
Why?
Severity of Illness Index
3
2023
140
0.120
Why?
Infant, Extremely Premature
1
2013
13
0.120
Why?
Virus Diseases
1
2013
11
0.120
Why?
Bacterial Infections
1
2013
27
0.120
Why?
Adolescent
4
2023
2015
0.120
Why?
Double-Blind Method
2
2018
44
0.120
Why?
Infant
4
2023
1389
0.120
Why?
Respiratory Tract Infections
1
2013
72
0.110
Why?
Mutation
2
2018
179
0.110
Why?
Plethysmography
1
2011
5
0.110
Why?
Oscillometry
1
2011
2
0.110
Why?
Spirometry
1
2011
6
0.110
Why?
Respiration
1
2011
6
0.110
Why?
Tobramycin
1
2021
3
0.110
Why?
Infant, Premature
3
2018
84
0.110
Why?
Azithromycin
1
2021
5
0.110
Why?
Pseudomonas aeruginosa
1
2021
7
0.110
Why?
Child, Preschool
2
2018
1465
0.110
Why?
Young Adult
2
2018
607
0.100
Why?
Acids
1
2010
1
0.100
Why?
Ear, Middle
1
2010
1
0.100
Why?
Pepsin A
1
2010
1
0.100
Why?
Mucin-5B
1
2010
1
0.100
Why?
Gene Expression
1
2010
57
0.090
Why?
Adult
2
2018
1121
0.090
Why?
Sweat
1
2018
1
0.090
Why?
Chlorides
1
2018
4
0.090
Why?
Drug Combinations
1
2018
16
0.090
Why?
Cells, Cultured
1
2018
70
0.090
Why?
Anti-Bacterial Agents
1
2021
245
0.090
Why?
Alleles
1
2018
158
0.080
Why?
Genotype
1
2018
297
0.080
Why?
Child
3
2023
3004
0.070
Why?
Reproducibility of Results
2
2017
179
0.070
Why?
Follow-Up Studies
2
2018
302
0.070
Why?
Retrospective Studies
2
2023
1232
0.060
Why?
Hospital Mortality
1
2023
21
0.060
Why?
Mice
2
2017
291
0.060
Why?
Animals
2
2017
628
0.050
Why?
Bronchoscopy
1
2018
8
0.040
Why?
Diagnosis, Differential
1
2018
78
0.040
Why?
Respiratory Rate
1
2017
3
0.040
Why?
Oxygen
1
2017
14
0.040
Why?
Cross-Over Studies
1
2017
32
0.040
Why?
Salmonella Infections
1
1997
1
0.040
Why?
Salmonella enterica
1
1997
1
0.040
Why?
Klebsiella pneumoniae
1
1997
3
0.040
Why?
Klebsiella Infections
1
1997
4
0.040
Why?
Tomography, X-Ray Computed
1
2018
122
0.040
Why?
beta-Lactamases
1
1997
7
0.040
Why?
Intensive Care Units, Neonatal
1
2017
33
0.040
Why?
Gestational Age
1
2017
65
0.040
Why?
Escherichia coli Infections
1
1997
20
0.040
Why?
Missouri
1
2017
78
0.040
Why?
Protein Stability
1
2017
1
0.040
Why?
Escherichia coli
1
1997
28
0.040
Why?
Breath Tests
1
2017
9
0.040
Why?
Cross-Sectional Studies
1
2017
292
0.040
Why?
Homozygote
1
2015
17
0.030
Why?
Drug Therapy, Combination
1
2015
41
0.030
Why?
Diuretics
1
2013
4
0.030
Why?
Oxygen Inhalation Therapy
1
2013
3
0.030
Why?
ROC Curve
1
2013
17
0.030
Why?
Infant, Very Low Birth Weight
1
2013
10
0.030
Why?
Logistic Models
1
2013
79
0.030
Why?
Middle Aged
1
2015
553
0.030
Why?
Prognosis
1
2013
174
0.030
Why?
Cohort Studies
1
2013
254
0.030
Why?
Risk Factors
1
2013
392
0.030
Why?
In Vitro Techniques
1
2010
21
0.020
Why?
Cell Survival
1
2010
16
0.020
Why?
Hydrogen-Ion Concentration
1
2010
20
0.020
Why?
Up-Regulation
1
2010
26
0.020
Why?
Cell Line
1
2010
70
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
80
0.020
Why?
RNA, Messenger
1
2010
129
0.020
Why?
Aztreonam
1
1997
1
0.010
Why?
Sputum
1
1997
2
0.010
Why?
Ceftazidime
1
1997
5
0.010
Why?
Drug Resistance, Microbial
1
1997
4
0.010
Why?
Microbial Sensitivity Tests
1
1997
37
0.010
Why?
Escobar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_